EIBIR Winter School on Interdisciplinary Biomedical Imaging

17-22 January 2010, Viladrau, Spain.
The main objective of the EIBIR Winter School is to support the interdisciplinary training of technical and clinical PhD students working in the broad area of biomedical imaging. In this first EIBIR Winter School on Interdisciplinary Biomedical Imaging, two key clinical disease areas will be addressed which altogether represent the two leading causes of death worldwide: cardiovascular and oncologic diseases. Each topic will be covered from the perspective of novel methods for biomedical image acquisition, analysis and interpretation as well as from the perspective of computational modeling and interventional planning, where appropriate. The themes will be explored based on the key driving clinical questions as well as from an understanding of the underlying disease mechanisms or pathophysiology.

The faculty will include lecturers with a clinical, biomedical and technical background, from both academia and industry. Reading groups, poster sessions and social activities will be offered.

Target Group
Second- and third-year students pursuing their graduate studies within PhD programs of biomedical engineering, computer science, electrical engineering, physics, medical physics, and medicine. Participants should have a basic understanding of biomedical imaging in terms of acquisition and image analysis and interpretation. Possibility to earn CME credits.

Location
Viladrau/Spain, about 70km from Barcelona, located within the Montseny Natural Park

Application
Via email to This email address is being protected from spambots. You need JavaScript enabled to view it., until October 22nd, 2009 including:

  • Curriculum Vitae including contact details of two referees and current main supervisor
  • Letter of intention
Number of participants admitted: 45 PhD students;

Notification of selected candidates: Before November 15th 2009

Participation fees
EUR 645,- (twin room)
EUR 795,- (single room)
Including attendance of the course, full board accommodation, bus from Barcelona to Viladrau and back, all social activities. Payment of registration fees before December 1st, 2009.

For further information, please visit:
http://www.eibir.org

About EIBIR
The European Institute for Biomedical Imaging Research (EIBIR) is a non-profit limited liability company that was founded in 2006 by the European Society of Radiology (ESR), dedicated to the co-ordination of research.

EIBIR has the aim of co-ordinating and supporting the development of biomedical imaging technologies and the dissemination of knowledge with the ultimate goal of improving diagnosis, treatment and prevention of disease.

The platform supports networking activities in research and is key to spreading good practice, promoting common initiatives and interoperability in the field of biomedical imaging research.

Most Popular Now

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...